Scientific article
French

Evaluation du risque hémorragique en cas de maladie thromboembolique veineuse: état des lieux en 2012

Published inRevue médicale suisse, vol. 8, no. 327, p. 320-323
Publication date2012
Abstract

About 2 to 2,5% of patients with venous thromboembolism suffer from a major bleed in the first 90 days of treatment with anticoagulation. Many predictors of hemorrhages have been identified, and include the stability of INRs, a bleeding history, cancer, chronic kidney disease and an advanced age. This knowledge may help care-providers to identify high-risk situations and to determine the best duration of treatment for their patients. Bleeding prediction rules for prevalent users of warfarin have not been validated for patients in venous thromboembolism, and their usefulness remains to be determined.

Keywords
  • Anticoagulants/administration & dosage/adverse effects
  • Hemorrhage/etiology/prevention & control
  • Humans
  • Risk Factors
  • Venous Thromboembolism/drug therapy
Citation (ISO format)
BLONDON, Marc, RIGHINI, Marc Philip. Evaluation du risque hémorragique en cas de maladie thromboembolique veineuse: état des lieux en 2012. In: Revue médicale suisse, 2012, vol. 8, n° 327, p. 320–323.
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
Additional URL for this publicationhttp://rms.medhyg.ch/numero-327-page-320.htm
Journal ISSN1660-9379
511views
0downloads

Technical informations

Creation29/10/2013 10:56:00
First validation29/10/2013 10:56:00
Update time27/01/2025 15:32:04
Status update27/01/2025 15:32:04
Last indexation27/01/2025 15:40:50
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack